Kingfisher keeps on hoping for more and more “home nesting” by us all
By Chris Bailey | Tuesday 20 September 2022
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Some GSK plc (GSK) shareholders have sold their Haleon (HLN) spin-off shares and some have not. I belong in the latter group on the basis that today’s half one numbers are a classic double or quits moment, based far more on the conference call being held by “one of the world's largest providers of specialist oral health” later today. I look forward to sharing some thoughts with you all on this tomorrow – as shown by the share price rise this morning, the numbers were alright…but what really matters is where the group is going over the rest of the decade. Meanwhile, a couple of months ago I wrote on Kingfisher (KGF).
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.